You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Aminoacetic Acid 1.5% In Plastic Container, and when can generic versions of Aminoacetic Acid 1.5% In Plastic Container launch?

Aminoacetic Acid 1.5% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER is glycine. There are thirty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glycine profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER?
  • What are the global sales for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER?
Summary for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
Drug patent expirations by year for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 017865-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Aminoacetic Acid 1.5% in Plastic Container

Last updated: July 31, 2025

Introduction

Aminoacetic acid, commonly known as glycine, is a simple non-essential amino acid with expanding applications in pharmaceutical, nutritional, and cosmetic industries. Its formulations, notably aminoacetic acid at a 1.5% concentration packaged in plastic containers, are gaining prominence owing to increasing demand for amino acid derivatives that serve various therapeutic and health-related functions. This analysis explores the current market landscape, growth drivers, competitive positioning, and projected financial trajectory of aminoacetic acid 1.5% in plastic containers.

Market Overview

The global aminoacetic acid market is witnessing steady growth, driven by rising applications in pharmaceuticals, dietary supplements, and cosmetics. The demand for amino acids as integral ingredients in injectable drugs, tablets, and topical formulations underscores the importance of product stability, container integrity, and regulatory compliance. Packaging solutions—specifically plastic containers—offer advantages such as cost efficiency, ease of handling, and chemical compatibility, making them the preferred choice for manufacturers.

The specific segment of aminoacetic acid 1.5% in plastic containers is specialized, serving both as an active pharmaceutical ingredient (API) or excipient across diverse formulations. The market size, while currently niche, exhibits significant expansion potential congruent with the growth trajectories of its end-use sectors.

Market Drivers

1. Increasing Adoption in Pharmaceutical Applications

Aminoacetic acid functions as a buffering agent, excipient, and active ingredient in various medications. Its role in treatments for neurological disorders, metabolic conditions, and nutritional deficiencies propels demand. The 1.5% concentration is particularly favored in certain formulations owing to its therapeutic efficacy and stability.

2. Rising Nutraceutical and Dietary Supplement Demand

As health consciousness surges globally, aminoacetic acid finds application in dietary supplements aimed at improving sleep, cognitive function, and metabolic health. This expanding consumer segment supports higher production volumes and procurement of aminoacetic acid in pre-measured, stable packaging, such as plastic containers.

3. Advantages of Plastic Container Packaging

Plastic containers facilitate protection against moisture, contamination, and degradation. They also support dosage accuracy and consumer convenience, essential for pharmaceutical and supplement products. Cost-effective production and widespread availability further strengthen their market position.

4. Regulatory and Quality Standards

Stringent regulatory standards necessitate high-quality packaging to ensure product stability. Technological advancements in plastic chemistries—such as the use of inert polymers—enhance compatibility with amino acids, reducing degradation risks and extending shelf life.

5. Emerging Regional Markets

Developing markets in Asia-Pacific, Latin America, and Africa are witnessing increasing pharmaceutical manufacturing activities, boosting demand for aminoacetic acid formulations. Growing healthcare infrastructure and increased R&D investments contribute to regional market growth.

Market Challenges

1. Competition from Alternative Packaging

While plastic remains dominant, alternative solutions like glass and bio-based materials are emerging, potentially impacting market share.

2. Price Fluctuations of Raw Materials

Volatility in raw material costs, especially for plastic resins, can influence production costs and profit margins.

3. Stringent Regulatory Compliance

Adherence to regulatory standards for pharmaceutical packaging varies across regions, requiring continuous investments in quality assurance.

Financial Trajectory and Forecast

The financial outlook for aminoacetic acid 1.5% in plastic containers hinges on multiple factors:

  • Market Growth Rate: Estimated compound annual growth rate (CAGR) of 6-8% over the next five years, driven by expanding pharmaceutical and nutraceutical markets [1].

  • Pricing Trends: Stable to slightly increasing, influenced by raw material costs and quality compliance overheads.

  • Production Volumes: Projected significant growth correlating with global health and wellness trends, with multinational pharmaceutical companies leading procurement.

  • Profitability: Margins remain healthy owing to economies of scale, especially if bundled with value-added packaging innovations.

  • Investment Outlook: Companies investing in high-quality plastic packaging manufacturing, alongside R&D for enhanced material compatibility, stand to capitalize on market expansion.

Key Financial Metrics to Watch

  • Revenue Expansion: As demand consolidates from global markets, revenue streams from aminoacetic acid products are expected to grow robustly.

  • Cost Management: Effective supply chain management of plastic resins and raw materials is crucial to preserving margins.

  • Market Penetration: Entry into emerging markets can significantly boost sales volumes and revenue.

  • Innovation and Differentiation: Developing novel packaging solutions that enhance product stability and consumer appeal can command premium pricing.

Competitive Landscape

Major industry players include pharmaceutical-grade chemical suppliers, packaging manufacturers, and integrators. Key features that determine competitive positioning involve product quality certifications, customization capabilities, supply chain reliability, and compliance with international standards such as FDA and EMA regulations.

Partnerships between amino acid producers and packaging firms facilitate integrated solutions, enhancing marketability and ensuring quality standards are maintained throughout product lifecycle.

Regulatory Environment

The regulatory landscape mandates compliance with Good Manufacturing Practices (GMP), packaging safety standards, and environmental guidelines. Due to its pharmaceutical application, aminoacetic acid 1.5% in plastic containers must meet rigorous safety and stability criteria, influencing manufacturing practices and certification processes.

Future Opportunities

  • Technological Innovations: Development of biodegradable plastics or advanced inert polymer formulations enhances environmental sustainability and product stability.

  • Market Diversification: Expanding into new therapeutic areas and nutraceutical segments broadens the customer base.

  • Digital Traceability: Implementing blockchain and digital tracking for supply chain transparency enhances trust and compliance.

Key Takeaways

  • The aminoacetic acid 1.5% in plastic container market is positioned for steady growth driven by increasing pharmaceutical and nutraceutical demand.

  • Cost-effective, chemically compatible plastic packaging solutions offer strategic advantages to manufacturers.

  • Market expansion into emerging regions presents significant revenue opportunities, contingent upon regulatory adaptation and supply chain scalability.

  • Investment in innovative, sustainable packaging materials and quality assurance practices will underpin competitive advantage.

  • Industry players should monitor raw material costs, regulatory changes, and consumer preferences to refine their strategic positioning.

FAQs

1. What are the primary applications of aminoacetic acid 1.5% in pharmaceuticals?

It functions as an excipient, buffering agent, and active ingredient in medications targeting neurological, metabolic, and nutritional conditions.

2. Why is plastic packaging preferred for aminoacetic acid formulations?

Plastic containers offer chemical inertness, moisture protection, cost-efficiency, ease of handling, and consumer convenience, making them ideal for pharmaceutical and nutraceutical products.

3. How will regulatory standards influence market growth?

Strict compliance requirements necessitate investment in high-quality, validated packaging solutions, which may initially increase costs but ensure product safety, thereby supporting sustainable growth.

4. Which regions are emerging as key markets for aminoacetic acid formulations?

Asia-Pacific, Latin America, and Africa are experiencing rapid pharmaceutical expansion, creating substantial demand for aminoacetic acid products in plastic containers.

5. What innovations could shape the future of this market?

Development of biodegradable plastics, advanced inert polymers, and digital traceability systems can enhance sustainability, product stability, and supply chain transparency.

References

[1] Industry analysts estimate a compound annual growth rate (CAGR) of 6-8% for amino acid markets through 2028, supported by expanding pharmaceutical and nutraceutical sectors.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.